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ABSTRACT 
The COVID-19 pandemic increases the risk of mortality and morbidity in patients with diabetes mellitus. This is due to the 
implementation of social restriction policies that can change patterns of physical activity, food consumption, psychological 
pressure, and medical history which will affect blood glucose management compliance in patients with DM. The purpose 
of this study was to determine the impact of the COVID-19 pandemic on blood glucose management in patients with DM. 
This study was literature review by searching four databases (Pubmed, Science direct, Microsoft Academic, and Wiley) 
for searches of past research on the same theme published in 2020-2021. The prism checklist is used as a protocol and 
evaluation, and critical appraisal is used to test the feasibility of the study results to be used. 12 articles were found that 
met the inclusion criteria. The results of the study consisted of case control, cohort, and cross sectional research with the 
total number of participants from 12 studies of 3,131 respondents. Things that affect the improvement of blood glucose 
management during the pandemic are the use of CGM, telemedicine, and improving the quality of life. While the things 
that affect the decrease in blood glucose management during the pandemic are the increase in psychological pressure, 
difficulty accessing health services, not monitoring blood glucose, as well as a decrease in physical activity and dietary 
compliance. The COVID-19 pandemic can affect improving blood glucose management and decreasing blood glucose 
management in patients with DM. 
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INTRODUCTION 
DM (Diabetes Mellitus) is often referred 
to as the silent killer because people who suffer 
from DM can affect the performance of all 
organs of the body and cause various complaints, 
such as visual disturbances, heart disease, kidney 
disorders, impotence, gangrene wounds, lung 
infections, blood vessel disorders, strokes, and 
others (Fatimah, 2015). Improving the quality of 
life of DM patients is needed so that the activities 
and lives of people with diabetes can still be 
carried out without being disturbed. Perform 
blood glucose control, behavior change with 
education, eating arrangements, physical 
activity, and adherence to medication. With 
proper management and control, it is expected to 
minimize the occurrence of complications in DM 
patients (Ramadhan et al., 2018). 
The new threat of increased morbidity 
and mortality of DM patients has been seen since 
the emergence of a new virus called The Novel 
Corona Virus Disease (COVID-19), where 
people who have a history of DM with 
uncontrolled blood glucose and are exposed to 
COVID-19 are more susceptible to worsening 
the disease (Zhu et al., 2020). Blood glucose 
management of DM patients is estimated to be 
disrupted due to the current pandemic conditions 
around the world. Policies such as social 
restrictions and lockdowns will of course change 
almost all of the activities and habits of the 
community, including people with DM. These 
changes can allude to various aspects related to 
blood glucose management, ranging from 
changes in food intake, physical activity, mental, 
economic, and others. 
How does the COVID-19 pandemic 
affect blood glucose management in DM 
patients? This literature summary aims to 
identify how much influence the COVID-19 
pandemic has on the blood glucose management 
of DM patients, so that it can be seen how the 
attitudes and readiness of the patients in carrying 
out blood glucose management so that unwanted 
acute and chronic complications can be 
prevented or minimized. 
 
MATERIAL AND METHODS 
This literature review was a scientific 
paper compiled through an integrated analysis of 
various journal articles according to the specified 
theme. The search for literature references was 
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carried out from March to April 2021. The data 
and information contained in this study were not 
the result of direct observation, but secondary 
data obtained from the results of research by 
previous researchers. The secondary data 
sources used were taken from national and 
international journal articles according to the 
theme "Impact of the COVID-19 Pandemic on 
Blood Glucose Management in Diabetes 
Mellitus Patients". Search literature references 
using databases with high quality criteria, 
namely Science Direct and Pubmed. As well as 
two other databases with moderate reputation, 
namely Wiley and Microsoft Academic. The 
prism checklist was used as a protocol and 
evaluation in determining study selection. 
The search for journal articles related to 
the theme is carried out using keywords and 
Boolean operators (AND, OR, or AND NOT) in 
order to deepen and specify the search in 
determining the journal articles to be used. The 
strategy used in the literature search is using the 
PICOS framework. 
Based on the results of a literature search 
through publications in the database and using 
keywords that have been adjusted to MeSH, the 
researchers found 188 articles from the four 
databases used. The reference results obtained 
were then checked for duplication, and found the 
same 6 journal articles so that they were 
excluded and the remaining 182 articles. Then, 
the title (n = 182), abstract (n = 73) and full text 
(n = 12) screening were carried out according to 
the topic of the literature review. Then, an 
assessment is carried out based on the feasibility 
of the inclusion and exclusion criteria, in order 
to obtain 12 articles that will be used. 
The results of the assessment of the 
quality of the study are carried out based on 
critical appraisal. Then an analysis of the 
methodological quality was carried out in each 
study (n = 12). The assessment criteria are given 
a score of 'yes', 'no', 'not clear' or 'not applicable', 
where each criterion with a value of 'yes' is given 
a score of one point, while other values are given 
a score of zero, and the final results are summed. 
If the research score is above 50%, it means that 
it meets the critical appraisal criteria. At the last 
screening, there were twelve articles that met a 
score of more than 50% and were ready for data 
synthesis so that the articles used in this literature 
review totaled 12 articles. 
 
RESULTS AND DISCUSSION 
The results of the search for studies that 
passed the inclusion criteria, used a cross-
sectional, cohort and case control study design. 
Overall, each study discusses how the COVID-
19 pandemic affects blood glucose management 
in patients with diabetes mellitus. Studies 
according to this systematic review were 
conducted from various countries, including 
Spain, Italy, Turkey, China, India, United 
Kingdom and Saudi Arabia. Among the 12 
studies used, 7 studies explained that the 
COVID-19 pandemic worsened blood glucose 
management in DM patients, and 5 other studies 
explained that DM patients' blood glucose 
management improved during the COVID-19 
pandemic. 
The total number of respondents from the 
12 literature search results is 3,131 respondents, 
with the majority of respondents being 1,255 
individuals. Respondents in this study were 
patients with type 1 DM and type 2 DM. The 
gender characteristics of the respondents in each 
article were mostly male. The age characteristics 
of the respondents in the research articles varied, 
ranging from children, adolescents, adults, and 
the elderly. All respondents are indigenous 
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Table 1. Literature Search Result 
Authors 
and years 




Summary of Results 
(Mesa et al., 
2020) 
Design : Case control study 
Sample : 92 patient with T1DM 
Variable : Patient with Type 1 Diabetes Treated with 
injection insulin 
Instrument : Glucose monitoring data between two 
periods, pre-COVID-19 lockdown and  within the 
COVID-19 lockdown 
Analysis : Chi Square 
Glucose control 
did not 






Slowing down routine 
daily activities can have 
beneficial in general 
population with T1DM 
(Aragona et 
al., 2020) 
Design : Case control study 
Sample : 63 patient with T1DM 
Variable : Patient whom used Flash Glucose Monitoring 
(FGM) and Continuous Glucose Monitoring (CGM) 
system 
Instrument : Average glucose, Glucose management 
indicator, Glucose variability 
Analysis : Chi Square 
The lockdown 





educated on diabetes 
management used FGM or 
CGM can effectively 
manage their glycemic 
control even pandemic 
(Predieri et 
al., 2020) 
Design : Case control study 
Sample : 62 children and adolescent with T1DM 
Variable : Patient with T1DM using the real-time CGM 
(Continuous Glucose Monitoring) system  
Instrument : anthropometry, Glycemic control, and 
insulin therapy 







Telemedicine and the real 
time CGM  
system together with the 
remote control access 
allowed us to report a large 




Design : Case control study 
Sample : 101 T2DM patients 
Variable : T2DM patients unable to attend follow-ups 
due to the lockdown 
Instrument : Demographic data, anthropometric 
measurements, dietary and exercise habits, anti-diabetic 
treatments, blood sugar measurement, frequencies of 
acute diabetic complication, and fasting glucose, 
postprandial glucose, HbA1c. 







In addition to control of 
glycemic parameters, 
patients also need to be 
supported emotionally, 
mentally, and in terms of 
social and physical 
functions 
(Tao et al., 
2020) 
Design : Cross-sectional study 
Sample : 1159 patients with T2DM and 96 patients with 
T1DM 
Variable : patient who discharged from the 
endocrinology department of a hospital from January 
2019 to January 2020. 
Instrument : Socio demographic variables, health risk 
variables, and adherence to self-management behaviors. 
Analysis : Chi-square 
Glycemic control 
among patients 





pandemic is poor. 
More education, a higher 
frequency of SMBG, and 
improved medication 
compliance may 
contribute to glycemic 
control. 
(Verma et al., 
2020) 
Design : Cross-sectional study 
Sample : 52 patients with T1DM 
Variable : T1DM patients were telephonically called at 
the end of lockdown period and asked to report within 15 
days 
Instrument : Data regarding hypoglycemic and 
hyperglycemic episodes, diabetic ketoacidosis, insulin 
dose missed, regular glucose monitoring, dietary 
compliance 









The factors responsible 
such as non availability of 
insulin/ glucose trips, poor 
dietary compliance and 
decreased physical 
activity need to be taken 
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(Wu et al., 
2021) 
Design : Cohort Study 
Sample : 43 children with T1DM 
Variable : Children with T1DM using continuous 
glucose management (CGM) 
Instrument : Demographic data and medical history from 
dataset of the T1DM China Registry Study 









Better control at baseline 
were more likely to 
achieve amelioration in 
hypoglycemia. More 
stable and slowed down 
rhythm might lead to 
better glycemic control, 
but lifestyle changes cloud 
not provide a long-term 
effect. 
(Navis et al., 
2021) 
Design : Case control study 
Sample : 269 patients with T1DM 
Variable : Patients were identified Freestyle Libre (FSL) 
or Dexcom G6 sensor users 
Instrument : Sensor data from Libreview and Dexcom 
clarity following periods pre-lockdown, early lockdown, 
and mid-lockdown 
Analysis : Chi-square 
Glycemic control 




Blood glucose control 
during the lockdown 
period is improved in 
people with diabetes 




Design : Cohort study 
Sample : 307 patient with diabetes 
Variable : Patient who had attended the endocrine OPD 
before lockdown due to COVID-19 and had HbA1c 
reporting in recent past 
Instrument : Questionnaire 





Significant increase of 
mean HbA1c in immediate 
post lockdown period 
which may significantly 
increase the annual 
incidence of 




Design : Cohort study 
Sample : 143 patient with T2DM 
Variable : Patients who had attended endocrine OPD in 
the last 3 months and had good glycemic control in the 
past without any chronic complications 
Instrument : Questionnaire 








difficulty in getting 
medication and medical 
advice were identified as 
possible factors for 




Design : Cross-sectional study  
Sample : 350 PWD 
Variable : Registered for care at diabetes clinic of a 
tertiary care center 
Instrument : Telephonic interviews : physician 
consultations, access to diabetes medications and blood 
sugar test, use of telemedicine services, out of pocket 
expenditure and psychological morbidity 




had a poor 
glycemic control 
during lockdown 
period and most 




The awareness about 
telemedicine services very 
low and Out Of Pocket 
Expenditures (OOPE) on  




Design : Cross-sectional study 
Sample : 394 participant 
Variable : Patient who had attended National Guard 
primary care center  
Instrument : Survey included question on demographic 
data, type of diabetes, medication used, comorbidities, 
medication compliance, and daily habits before and after 
the lockdown 








reduced after the 
lockdown 
Health-care need to 
encourage diabetes 
patients to adhere  to 
healthy lifestyle habit and 
use telemedicine during 
the lockdown in order to 
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The COVID-19 Pandemic Increased Blood 
Glucose Management 
a. Use CGM (Continuous Glucose 
Monitoring) 
In the strict lockdown conditions 
imposed during the COVID-19 pandemic, 
type 1 DM patients who have a history of 
being prone to hypoglycemia and using 
CGM technology have managed to control 
glycemic well. (Predieri et al., 2020). CGM 
technology is considered to be able to help 
prevent the occurrence of hypoglycemia in 
clients because CGM has a feature that 
allows patients to receive an alarm in the 
form of a signal that will warn the patient if 
blood glucose levels increase or decrease 
below normal levels, which are adjusted 
based on the settings prepared by the health 
care provider (Lin et al., 2020). When 
patients use CGM technology, health 
workers can easily access and find out data 
on fluctuations in the patient's glucose 
levels. Patients who receive a signal that 
blood glucose begins to fall below the 
normal range can immediately initiate self-
prevention of hypoglycemia.  
 
b. Use telemedicine 
The COVID-19 pandemic has 
become the reason for the widespread use 
of telemedicine technology for DM 
patients who have high risk, especially in 
patients with type 1 DM. (Aragona et al., 
2020). Patients and health workers who use 
telemedicine can streamline services in 
monitoring, evaluation, and education. 
Using telemedicine will help patients who 
find it difficult to come to health services 
so that they can report their symptoms and 
can receive advice and direction regarding 
their illness (Lubis, 2021). DM sufferers 
who experience limited access during the 
lockdown period can easily get 
consultation and advice from medical 
personnel. Insulin doses, complaints and 
disease progression, prevention of 
complications, especially in type 1 DM 
patients who are very susceptible to 
hypoglycemia should be monitored 
regularly, and telemedicine is the most 
appropriate and safe option during the 
COVID-19 pandemic.  
 
c. Improved quality of life 
Type 1 DM patients at the beginning 
of the lockdown have more time to focus 
on timing insulin injections and food 
composition (Navis et al., 2021). Based on 
the results of the study, people are more 
likely to adopt a healthy diet during the 
COVID-19 pandemic. People are 
encouraged to improve their diet, such as 
eating a complete composition, increasing 
consumption of fruits and vegetables, 
meeting fluid needs, limiting consumption 
of fat, sugar, and salt, and improving food 
hygiene. (Afifah, dictation in Tampatty et 
al., 2020). During the COVID-19 
pandemic, this can be maximized by taking 
advantage of the lockdown and social 
restrictions policies because more and 
more time is available for self-management 
and DM management. 
 
The COVID-19 Pandemic Decreased Blood 
Glucose Management 
a. Increased psychological stress 
Most type 2 DM patients reported 
increased psychological stress and 
decreased sleep quality during the COVID-
19 pandemic (khare & jindal, 2020). The 
COVID-19 pandemic period can affect the 
psychological condition of various scopes, 
including the academic scope for students 
who experience learning limitations, the 
work scope for people who have lost 
income, and the family scope created by 
the aggregation of academic and work 
pressures. (Muslim, 2020). The entire 
community has directly experienced the 
impact of the COVID-19 pandemic, which 
includes feeling limited in their activities, 
decreasing economic turnover, workers' 
concerns about layoffs and online learning 
models that make students feel bored and 
bored. This leads to an increase in 
psychological stress and leads to a decrease 
in blood glucose management.  
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b. Difficulty accessing health service 
Type 2 DM patients in India find it 
difficult to participate in online-based 
alternative health care programs (Olickal et 
al., 2020). Health services for patients with 
chronic diseases such as DM during the 
COVID-19 pandemic must find alternative 
methods so that acute worsening and 
complications that can threaten life do not 
occur. (WHO, 2020). Alternative health 
services that are considered the most 
appropriate in a crisis situation like this are 
telemedicine technology and the use of 
health applications. However, there can be 
several obstacles such as internet network 
difficulties for patients in rural areas, not 
having a smartphone in underprivileged 
patients, and the inability to operate a 
smartphone which often occurs in elderly 
DM patients. This can prevent DM patients 
from getting health consultations during 
the COVID-19 pandemic. 
 
c. Not monitoring blood glucose  
The main reason for type 2 DM 
patients in India not to monitor blood 
glucose levels is the unavailability of 
glucose strips during the COVID-19 
pandemic (Verma et al., 2020). In the early 
phases of the lockdown, the supply of 
medicines was continuously affected. 
Transportation of supplies for insulin and 
glucose strips is constrained, making it 
difficult to ensure a sustainable supply of 
pharmacotherapy (Tao et al., 2020). The 
unavailability of glucose strips prevents 
DM patients from checking their blood 
glucose levels. Whereas DM patients are 
recommended to routinely check blood 
glucose levels even though there are no 
symptoms of hypoglycemia or 
hyperglycemia. By routinely checking 
blood glucose, patients can adjust the dose 
of oral glycemic drugs and insulin doses to 
be used. 
 
d. Decreased physical activity and dietary 
compliance 
The results of the study on type 2 DM 
patients in Turkey showed an increase in 
body weight during the lockdown period 
(Önmez et al., 2020). There was a change 
in eating patterns during the COVID-19 
pandemic caused by the increase in food 
portions, the frequency of snacks, the 
frequency of cooking at home, as well as 
the frequency of vegetables and fruit. 
(Noviasty & Susanti, 2020). During the 
COVID-19 pandemic, people experienced 
an increase in the desire for carbohydrate-
rich snacks because they were influenced 
by psychological pressure while staying at 
home. In addition, feeling bored from 
spending hours at home during quarantine 
has resulted in a drastic increase in the 
frequency of eating. This is exacerbated by 
the decrease in physical activity during the 
pandemic so that weight gain and the diet 
pattern of DM patients become messy.  
 
CONCLUSIONS 
The COVID-19 pandemic has both 
positive and negative effects on blood glucose 
management in DM patients. Things that affect the 
improvement of blood glucose management in DM 
patients include the use of CGM technology, the 
use of telemedicine, and improving the quality of 
life. While the things that affect the decrease in 
blood glucose management in DM patients include 
psychological pressure, patient difficulties in 
accessing health services, not monitoring blood 
glucose, decreased physical activity, and failure to 
maintain a diet pattern. DM patients should be 
given comprehensive education to improve proper 
blood glucose management during the COVID-19 
pandemic. Further research is needed to assess the 
readiness of DM patients in preparing for blood 
glucose control in a state of social restriction so that 
the decrease in blood glucose management and the 
increased risk of morbidity and mortality of DM 
patients can be prevented. 
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